CDH2 and posterior cortical atrophy: In PCa, EMT is also a key process leading to metastases in the late stages of the disease, which is typically characterized by up-regulation of mesenchymal markers such as vimentin and N-cadherin and down-regulation of epithelial markers such as E-cadherin [29].